-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on BeOne Medicines, Raises Price Target to $454

Benzinga·08/06/2026 19:33:59
Listen to the news
TD Cowen analyst Yaron Werber maintains BeOne Medicines (NASDAQ:ONC) with a Buy and raises the price target from $424 to $454.